Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 303-757-8 | CAS number: 94213-53-3
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro gene mutation study in bacteria (Ames test)
Not mutagenic
In vitro gene mutation study in mammalian cells (Mouse Lymphoma Assay)
Not mutagenic
in vitro cytogenicity / micronucleus study (Human Lymphocytes test)
Not clastogenic
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
There is no complete information about the genetic toxicity of Direct Violet 051, therefore, the available data on structural analogous Similar Substance 01 have been taken into account. The read across approach can be considered as reliable and adequate for the purpose; details and explanations are detailed in the report attached to the IUCLID section 13.
In vitro gene mutation study in bacteria (Ames test)
In an Ames test the salified form of the Target substance (sodium salt) was tested in Salmonella typhimurium strains TA1535, TA1537, TA98, TA102 and TA100 in presence and absence of metabolic activation. As the substance is an azo-dye the Prival Mitchell modification was included in the test design. No increase in mutant frequency was reported in any of the strains tested both in presence and absence of metabolic activation. The substance is considered to be non-mutagenic under the conditions of this test.
Negative results were also obtained in a test carried out on Similar Substance 01, were no increase in mutant frequency was reported in any of the strains tested both in presence and absence of metabolic activation.
In vitro gene mutation study in mammalian cells (Mouse Lymphoma Assay)
Similar Substance 01 was tested in the L5178Y TK +/- Mouse Lymphoma Assay according to OECD 490 up to precipitation level. Exposure was either 4 hours (with and without metabolic activation) or 24 hours (without metabolic activation). No increase in the mutant frequency at the TK +/- locus was reported (evaluation with the Global Evaluation Factor (GEF) of 126 E-06). Therefore it is concluded that the substance is non-mutagenic in this assay.
in vitro cytogenicity / micronucleus study (Human Lymphocytes test)
Similar Substance 01 was tested in an in vitro micronucleus test (OECD 487). Human lymphocytes were exposed for 4 hours (with and without metabolic activation) or 24 hours (without metabolic activation). After the exposure cytokinesis was inhibited by treatment with Cytochalasin B. There was no inhibition of the CBPI and the concentrations to be evaluated were limited by precipitate at 128 ug/mL. No increase in the percentage of micronucleated binuclear cells was observed in any of the treatments. Therefore it can be concluded that the substance is not clastogenic.
Justification for classification or non-classification
Based on the outcome of the available in vitro tests, the substance does not need to be classified for mutagenicity according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
